Orthofix Medical Inc. Future Amortization Expense, Remainder of Fiscal Year (Deprecated 2012-01-31)
Orthofix Medical Inc. (OFIX) reported Future Amortization Expense, Remainder of Fiscal Year (Deprecated 2012-01-31) of $1.00 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-07-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseRemainderOfFiscalYear · last filed 2012-07-30
- Orthofix Medical Inc. future amortization expense, remainder of fiscal year (deprecated 2012-01-31) for the quarter ending 2012-06-30 was -$3.00M.
- Orthofix Medical Inc. future amortization expense, remainder of fiscal year (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $4.00M.
| Period end | Future Amortization Expense, Remainder of Fiscal Year (Deprecated 2012-01-31) 3 month | Future Amortization Expense, Remainder of Fiscal Year (Deprecated 2012-01-31) 6 month |
|---|---|---|
| 2012-06-30 | -$3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30 | $1.00M 10-Q · filed 2012-07-30 |
| 2012-03-31 | $4.00M 10-Q · filed 2012-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |